Pharmacyclics LLC, an AbbVie company, will host a presentation on IMBRUVICA® (i
Pharmacyclics LLC, invites you to attend a Multidisciplinary Discussion during the 2022 ASH Annual Meeting on Incorporating Imbruvica® (ibrutinib) into treatment strategies. The program will be held on Monday December 12th from 8:00 to 9:00 AM in Exhibit Hall/Theater 7 during the ASH Annual Meeting. Session sponsored by Pharmacyclics LLC, an AbbVie company and […]
Read More...